Media Centre
Media Relations
Publications and Magazines
Contact Us

News from the JGH 
Back to full list
March: Colorectal Cancer Awareness Month

The Jewish General Hospital (JGH) has a new, non-surgical protocol for treating patients with colorectal cancer. Immediately after the conventional treatment (radiation therapy and chemotherapy), this new research protocol uses brachytherapy treatment, in conjunction with an additional week of external radiation therapy. If the tumour disappears, the patient remains under observation. If the tumour does not disappear, the patient undergoes surgery.

Brachytherapy is a precisely targeted, non-invasive intervention that enables a high dose of radiation to be applied directly to the tumour. Brachytherapy was developed 20 years ago by Dr. Te Vuong, Chief of the Division of Radiation Oncology at the JGH, a member facility of CIUSSS West-Central Montreal.

In this instance, the JGH has once again demonstrated a sustained effort to improve the quality of patients’ lives through research and technological innovation, while considerably reducing the cost to the healthcare system by avoiding surgery. 

Dr. Vuong is available for interviews, along with her patients.